Access Statistics for Iain M. Cockburn

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Mixed Poisson Regression Model for Analysis of Patent Data 0 0 0 290 0 0 4 1,739
Are All Patent Examiners Equal? The Impact of Examiner Characteristics 0 0 0 366 0 2 8 2,006
Balancing Incentives: The Tension Between Basic and Applied Research 0 0 1 419 0 0 3 1,885
Characteristics of Demand for Pharmaceutical Products: an Examination of four Cephalosporins 0 0 0 0 1 2 4 2,373
Deals Not Done: Sources of Failure in the Market for Ideas 0 0 0 31 0 0 1 98
Do Patents Matter?: Empirical Evidence after GATT 0 0 0 297 0 0 1 819
Entry and Patenting in the Software Industry 0 0 1 191 0 0 7 642
Faster, Smaller, Cheaper: An Hedonic Price Analysis of PDAs 0 0 0 101 0 1 1 401
Generics and New Goods in Pharmaceutical Price Indexes 0 0 0 266 0 0 1 1,209
Gone But Not Forgotten: Labor Flows, Knowledge Spillovers, and Enduring Social Capital 0 0 0 269 0 0 3 837
Hedonic Analysis of Arthritis Drugs 0 0 0 163 0 0 1 1,015
Industry Effects and Appropriability Measures in the Stock Markets Valuation of R&D and Patents 0 2 3 390 0 2 6 1,166
Is Distance from Innovation a Barrier to the Adoption of Artificial Intelligence? 0 0 19 19 1 1 23 23
Is Distance from Innovation a Barrier to the Adoption of Artificial Intelligence? 0 1 23 23 1 2 43 43
Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs 0 0 0 157 0 1 3 1,636
Is distance from innovation a barrier to the adoption of artificial intelligence 10 18 18 18 8 24 31 31
Is distance from innovation a barrier to the adoption of artificial intelligence 2 2 20 20 2 4 31 31
Market Conditions and Retirement of Physical Capital: Evidence fron Oil Tankers 0 0 0 44 0 0 1 473
Measuring competence?: exploring firm effects in pharmaceutical research 0 0 0 510 1 2 9 1,343
Not Invented Here? Innovation in Company Towns 0 0 0 83 0 0 3 332
Patent Thickets, Licensing and Innovative Performance 0 1 1 130 0 1 3 413
Patent thickets, licensing and innovative performance 0 0 0 58 0 0 2 152
Patents and the Global Diffusion of New Drugs 0 0 0 52 0 0 0 116
Patents and the Global Diffusion of New Drugs 0 0 0 30 0 0 2 99
Patents and the Global Diffusion of New Drugs 0 0 0 74 0 0 2 161
Patents and the Survival of Internet-related IPOs 0 0 0 84 0 0 0 293
Patents and the global diffusion of new drugs 0 0 1 20 0 0 1 88
Patents and the global diffusion of new drugs 0 0 0 54 0 0 0 86
Patents, Thickets, and the Financing of Early-Stage Firms: Evidence from the Software Industry 0 1 3 104 0 1 4 349
Price Indexes for Clinical Trial Research: A Feasibility Study 1 1 3 32 3 4 17 115
Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research 0 0 1 125 2 2 5 367
Public-Private Interaction and the Productivity of Pharmaceutical Research 1 1 2 189 1 2 6 764
Racing or spilling?: the determinants of research productivity in ethical drug discovery 0 0 0 53 0 0 1 188
Racing to invest?: the dynamics of competition in ethical drug discovery 0 1 1 297 0 2 2 600
Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery 0 0 0 1 1 3 6 497
Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry 0 2 4 362 2 4 15 1,084
Scale, scope and spillovers: the determinants of research productivity in ethical drug discovery 0 0 0 145 0 1 5 329
The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research 0 1 2 310 0 1 22 1,968
The Impact of Artificial Intelligence on Innovation 2 11 25 411 17 69 166 3,324
The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity 0 0 0 56 1 1 4 103
University Research, Industrial R&D, and the Anchor Tenant Hypothesis 0 1 1 229 1 2 8 948
Why are Some Regions More Innovative than Others? The Role of Firm Size Diversity 0 0 0 100 0 0 4 285
Why are some regions more innovative than others? The role of firm size diversity 0 0 0 87 0 0 0 89
Total Working Papers 16 43 129 6,660 42 134 459 30,520


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery 1 2 6 25 7 18 37 89
Access to intellectual property for innovation: Evidence on problems and coping strategies from German firms 0 0 0 23 0 0 5 124
Analysis of Patent Data--A Mixed-Poisson-Regression-Model Approach 0 0 0 0 0 0 3 933
Canada’s Patent Productivity Paradox: Recent Trends and Implications for Future Productivity Growth 0 0 7 11 0 10 53 72
Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins 1 1 1 411 1 1 7 1,169
Deals not done: Sources of failure in the market for ideas 0 0 2 9 0 1 9 80
Diffusion of New Drugs in the Post-TRIPS Era 0 1 1 54 0 1 2 170
Entry and Patenting in the Software Industry 0 0 0 44 1 1 8 250
Faster, smaller, cheaper: an hedonic price analysis of PDAs 0 0 0 41 0 0 1 258
Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy 0 0 0 26 0 0 2 102
Generics and New Goods in Pharmaceutical Price Indexes 0 0 1 234 0 2 5 930
Generics and New Goods in Pharmaceutical Price Indexes: Reply 0 0 0 35 0 0 1 171
Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents 0 1 6 364 1 3 33 1,248
Information Technology and Intangible Output: The Impact of IT Investment on Innovation Productivity 0 1 8 44 0 4 21 148
Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs 0 0 0 29 0 1 3 390
Measuring Competence? Exploring Firm Effects in Pharmaceutical Research 0 0 2 18 5 8 19 130
New Pills for Poor People? Empirical Evidence after GATT 0 0 3 239 0 0 5 521
Not Invented Here? Innovation in company towns 0 0 1 51 0 1 8 366
Opportunity costs and entrepreneurial activity 0 0 0 158 0 3 3 473
Patent thickets, licensing and innovative performance 0 0 0 44 1 4 8 163
Patents and the Global Diffusion of New Drugs 0 0 2 78 3 6 13 391
Patents and the survival of Internet-related IPOs 0 1 2 98 0 3 9 407
Patents, Thickets and the Financing of Early‐Stage Firms: Evidence from the Software Industry 0 1 5 80 2 3 13 350
Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs 0 0 0 0 1 1 2 19
Pharmaceutical Innovations and Market Dynamics: Tracking Effects on Price Indexes for Antidepressant Drugs 0 0 2 5 0 2 11 38
Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research 0 0 0 15 1 2 6 101
Racing To Invest? The Dynamics of Competition in Ethical Drug Discovery 0 0 1 12 0 2 14 645
Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research 0 0 2 260 0 4 10 646
Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery 0 2 5 631 0 5 27 1,953
The Economics of Reproducibility in Preclinical Research 0 0 1 10 0 1 6 56
The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions 0 0 0 6 0 1 2 51
The Impact of Incremental Innovation in Biopharmaceuticals 0 0 0 17 0 1 4 67
The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems 0 2 10 216 1 3 21 695
Untangling the origins of competitive advantage 0 1 1 7 0 1 2 32
Why are some regions more innovative than others? The role of small firms in the presence of large labs 0 0 0 80 1 1 12 328
Total Journal Articles 2 13 69 3,375 25 94 385 13,566
1 registered items for which data could not be found


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Comment on "The Confederacy of Heterogeneous Software Organizations and Heterogeneous Developers: Field Experimental Evidence on Sorting and Worker Effort" 0 0 0 3 0 0 1 39
Comments on Nathan Rosenberg’s ‘Critical Episodes in the Progress of Medical Innovation’ 0 0 0 1 0 0 1 11
Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D 0 0 0 22 0 0 1 81
Hedonic Analysis of Arthritis Drugs 0 0 0 16 0 2 6 72
Is Price Inflation Different for the Elderly? An Empirical Analysis of Prescription Drugs 0 0 2 10 0 1 4 84
Is the Pharmaceutical Industry in a Productivity Crisis? 0 0 1 75 0 0 6 439
Not Invented Here? Innovation in Company Towns 0 0 0 0 0 0 7 201
Patents, Thickets and the Financing of Eastly-Stage Firms; Evidence from the Software Industry 0 0 0 22 0 0 2 136
Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research 0 0 0 0 0 0 0 91
Publicly Funded Science and the Productivity of the Pharmaceutical Industry 0 0 1 82 0 2 10 290
The Global Location of Biopharmaceutical Knowledge Activity: New Findings, New Questions 0 0 0 15 0 0 0 68
The Impact of Artificial Intelligence on Innovation: An Exploratory Analysis 1 3 23 381 3 11 62 1,049
The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity 0 1 3 36 2 5 9 142
Total Chapters 1 4 30 663 5 21 109 2,703


Statistics updated 2025-07-04